ZYME

Zymeworks Inc. · Healthcare · Market cap $1.8B

Insiders sold $1.8M net in the last 90 days ·3 sellers, 0 buyers· latest Form 4 filed Nov 18, 2026

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$6.4M

reported sales (SEC code S)

Unique Insiders

6

in the rolling window

Latest filing

Nov 18, 2026

Platshon Scott

Zymeworks Inc. (ZYME) has 13 SEC Form 4 filings (30 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Nov 18, 2026.

Inside the rolling window, 6 insiders at Zymeworks Inc. reported no open-market purchases and 11 open-market sales totaling $6.4M. The most active filer is Chief Scientific Officer Moore Paul Andrew with 3 filings. Insiders have net sold $1.8M over the trailing 6 months. The most recent open-market filing is a sale of 15,292 shares by EVP, Chief Business Officer Platshon Scott, dated Nov 18, 2026, worth $382K.

  • Industry:Biotechnology
  • CEO:Kenneth H. Galbraith
  • Employees:231
  • HQ:Middletown, DE, US
  • IPO:2017-04-28
Source
Platshon ScottFirst filing
Sale$382KNov 18SEC ↗
Moore Paul AndrewFirst in 10 months
Sale$1.0MNov 16SEC ↗
Schayowitz AdamFirst filing
Sale$358KOct 9SEC ↗
Hollywood MarkFirst filing
Sale$139KJan 13SEC ↗
Sale$217KJan 12SEC ↗
Sale$690KJan 12SEC ↗
Sale$211KJan 12SEC ↗
Sale$1.4MJan 5SEC ↗
Moore Paul AndrewFirst filing
Sale$505KJan 5SEC ↗
Smith Jeffrey T LFirst filing
Sale$264KJan 5SEC ↗
Galbraith KennethFirst filing
Sale$1.3MDec 22SEC ↗
Showing 1–11 of 11
1 / 1

Earnings: last 7 quarters

EstimatedActual

Frequently asked questions

How many SEC Form 4 insider filings does ZYME have?

Zymeworks Inc. (ZYME) has 13 SEC Form 4 filings (30 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Nov 18, 2026.

When was the most recent SEC Form 4 filing for ZYME?

The most recent Form 4 filing for ZYME on Tracefour is dated Nov 18, 2026.

Who is the most active insider at ZYME?

The most active SEC Form 4 filer at ZYME in the rolling window is Chief Scientific Officer Moore Paul Andrew, with 3 filings.

What is the net insider flow at ZYME over the last 6 months?

Over the trailing 180 days, insiders at ZYME have net sold $1.8M based on SEC Form 4 disclosures.

What is the total insider buy and sell value at ZYME in the current window?

Inside the rolling window, insiders at ZYME bought $0 and sold $6.4M based on SEC Form 4 filings.

Can I get alerts for ZYME insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Zymeworks Inc. (ZYME). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Zymeworks Inc. is in the Healthcare sector.